“Prednisone Withdrawal In Kidney Transplant Recipients On Cyclosporine And Mycophenolate Mofetil--A Prospective Randomized Study. Steroid Withdrawal Study Group.”. Transplantation 68 (12). Transplantation: 1865-74. doi:10.1097/00007890-199912270-00009.
. 1999. “Prednisone Withdrawal In Kidney Transplant Recipients On Cyclosporine And Mycophenolate Mofetil - A Prospective Randomized Study”. Transplantation 12. Transplantation: 1865-74.
. 1999. “Improved Graft Survival After Renal Transplantation: An Analysis Of United Network For Organ Sharing (Unos) Data”. N Engl J Med 342. N Engl J Med: 605-12.
. 2000. “Relationship Between Underlying Renal Disease And Renal Transplantation Outcome.”. Am J Kidney Dis 37 (6). Am J Kidney Dis: 1152-61. doi:10.1053/ajkd.2001.24516.
. 2001. “The Relationship Between Underlying Renal Disease And Renal Transplantation Outcome”. Am J Kidney Dis. Am J Kidney Dis: 37.
. 2001. “A Comparison Between Recipients Receiving Matched Kidney And Those Receiving Mismatched Kidney From The Same Cadaver Donor”. Am J Transplant 2. Am J Transplant: 366-372. http://www.ncbi.nlm.nih.gov/pubmed/12118860.
. 2002. “Evaluation Of Intravenous Immunoglobulin (Ivig) As An Agent To Lower Allosensitization And Improve Transplantation In Highly-Sensitized Adult Esrd Patients: Report Of The Nih Ig02 Trial”. J Am Soc Nephrol. J Am Soc Nephrol: 3256-3262.
. 2004. “A Randomized Multicenter Trial Of Okt3 Mabs Induction Compared With Intravenous Cyclosporine In Pediatric Renal Transplantation”. Pediatric Transplantation 9. Pediatric Transplantation: 282-292. http://www.ncbi.nlm.nih.gov/pubmed/15910382.
. 2005. “Safety And Efficacy Of A Calcineurin-Inhibitor Avoidance Regimen In Pediatric Renal Transplantation”. J Am Soc Nephrol 17. J Am Soc Nephrol: 1735-1745. http://www.ncbi.nlm.nih.gov/pubmed/16687625.
. 2006.